MedTrace Logo

Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19

NCT04635618 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 999

Last updated 2020-11-19

No results posted yet for this study

Summary

The study consists in a pragmatic superiority randomized controlled trial comparing different strategies of psychotherapy for professionals and students from essential services with high levels of emotional distress during the COVID-19 pandemic in Brazil. Therapeutic strategies to be evaluated are Brief Cognitive Behavioral Telepsychotherapy, Brief Interpersonal Telepsychotherapy and Telepsychoeducation, as an active control.

Note: This study was approved by the Ethics and Research Committee of the Hospital de Clínicas de Porto Alegre and is originally registered at Plataforma Brasil, a Brazilian study registration platform (under CAAE: 30608420.5.0000.5327). Recruitment began in May 28th 2020.

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioral Brief-Telepsychotherapy

Four sections of Cognitive Behavioral Brief-Telepsychotherapy plus personalized pre-recorded videos

BEHAVIORAL

Brief Interpersonal Telepsychotherapy

Four sections of Brief Interpersonal Telepsychotherapy plus personalized pre-recorded videos

BEHAVIORAL

Telepsychoeducation

A single session psychoeducation group plus weekly personalized pre-recorded videos for 4 weeks

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Giovanni Salum, MD, PhD · Hospital de Clínicas de Porto Alegre, Porto Alegre/Brazil

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-05
Primary Completion
2021-07-13
Completion
2021-07-20

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04635618 on ClinicalTrials.gov